Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
Details for Australian Patent Application No. 2004212263 (hide)
International Classifications
Event Publications
6 October 2005 PCT application entered the National Phase
PCT publication WO2004/071536 Priority application(s): WO2004/071536
22 December 2005 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 16 Sep 2005
21 September 2006 Assignment before Grant
Upperton Limited The application has been assigned to Upperton Limited; Novozymes Delta Limited
6 March 2008 Alteration of Name
The name of the applicant has been altered to Upperton Limited; Novozymes Biopharma UK Limited
3 December 2009 Application Accepted
Published as AU-B-2004212263
25 March 2010 Assignment before Grant
Novozymes Biopharma UK Limited; Upperton Limited The application has been assigned to Upperton Limited; Novozymes Biopharma DK A/S
1 April 2010 Standard Patent Sealed
13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser